Page 1354 - Problem-Based Feline Medicine
P. 1354

1346  PART 16  DRUGS


          with doses used in dogs (2.2 mg/kg and 1.1 mg/kg on  Dermal atrophy has also been reported in a cat treated
          alternate days).                              with phenytoin.
          In addition to dose-related marrow toxicity, idiosyn-
          cratic severe, irreversible, fatal leukopenia and throm-
                                                        PROPYLTHIOURACIL
          bocytopenia has also been reported in cats.
          They may lack thiopurine methyl transferase (TPMT),  Clinical action
          the enzyme necessary to degrade the 6-mercaptopurine  Anti-thyroid.
          active metabolite of azathioprine although this is not
          proven.
                                                        Why shouldn’t it be used in cats?
          The recommended dose in cats (0.3 mg/kg) and the sin-  Adverse effects from PTU include lethargy, weakness,
          gle size tablet of 25 mg means that reformulation is  anorexia and bleeding diathesis due to induction of
          necessary as clients must not split the coating of cyto-  immune-mediated disease.
          toxic drugs.
                                                        Nine of 105 cats developed serious side effects in a
          Chlorambucil is a better alternative in cats.  study of cats with hyperthyroidism.
                                                        Methimazole or carbimazole are the preferred drugs of
          BENZOCAINE                                    choice for treating feline hyperthyroidism.

          Clinical action
          Topical local anesthetic.
                                                        SCOPOLAMINE

          Why shouldn’t it be used in cats?             Clinical action
          Topical application can cause  methemoglobinemia,  Anti-emetic.
          laryngeal application can cause laryngeal edema.
                                                        Why shouldn’t it be used in cats?
          CISPLATIN                                     Short half life.


          Clinical action                               Tendency to cause behavioral changes.
          Cytotoxic.

                                                        SODIUM PHOSPHATE
          Why shouldn’t it be used in cats?
          Cisplatin causes fatal, acute pulmonary edema in cats
                                                        Clinical action
          and should not be used in this species.
                                                        Retention enemas.
          PHENYTOIN                                     Why shouldn’t it be used in cats?
                                                        Active ingredients can be rapidly absorbed through the
          Clinical action                               rectal mucosa resulting in potentially fatal hyperphos-
          Anti-convulsant.                              phatemia, hypocalcemia, hypernatremia, hyperosmo-
                                                        lality and metabolic acidosis.
          Why shouldn’t it be used in cats?             Clinical signs observed include  depression, ataxia,
                                                        vomiting and bloody diarrhea.
          Prolonged half life (>40 hours) compared to dogs
          resulting in rapid accumulation and development of  Dehydrated or debilitated cats are particularly sus-
          adverse signs such as sedation, ataxia and anorexia.  ceptible.
   1349   1350   1351   1352   1353   1354   1355   1356   1357   1358   1359